Publicaciones en colaboración con investigadores/as de Centre Hospitalier Universitaire de Nantes (2)

2022

  1. Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 1, pp. 52-62

2018

  1. Phase 3 trial of Ibrutinib plus rituximab in Waldenstrom's macroglobulinemia

    New England Journal of Medicine, Vol. 378, Núm. 25, pp. 2399-2410